𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Software for Speech Signal Research in Patients with Malignant Diseases of the Throat

✍ Scribed by V. P. Bondarenko; A. N. Kvasov; A. A. Konev; R. V. Meshcheryakov; E. L. Choinzonov; S. Yu. Chizhevskaya

Book ID
106362402
Publisher
Springer US
Year
2009
Tongue
English
Weight
339 KB
Volume
43
Category
Article
ISSN
0006-3398

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risk of malignant lymphoma in patients w
Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study
✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 319 KB πŸ‘ 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose

The clinical use of bone resorption mark
The clinical use of bone resorption markers in patients with malignant bone disease
✍ Robert E. Coleman πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 278 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Advanced tumors often metastasize to bone, resulting in a variety of skeletal complications. Bisphosphonates are potent inhibitors of osteoclast‐mediated bone resorption that reduce the incidence and delay the onset of skeletal complications and reduce the need for radiat